Web pick posted by Neil Savage, Xconomy.com
Bioterrorism Work Since 9/11 Leads to Modest Gains
The US has spent more than $57 billion on bioterrorism defense in the last seven years, from stockpiling drugs to setting up networks of bioweapon-sensors around major cities. The result of all that effort, says the Washington Post, is only a modest gain in preparedness. Experts say the country needs to develop a general-use anthrax vaccine and a new generation of sensors, as well as take other steps.
Top Innovation Stories
Partners
Recent Posts
- Auction Sets Carbon Emissions at $3.07 per Ton
- Bacteria Can Produce Plastic
- A Different Digital Divide: Age
- NASA Reauthorization Passes, Astronauts to Return to the Moon
- Digitizing Health Records Still a Challenge
- Boeing Begins Jet Biofuel Initiative
- Obama Releases Science Funding Plan
![[RSS]](http://67.192.49.194/templates/images/rss_icon.gif)
Subscribe to RSS feed
Post A Comment